Mutual of America Capital Management LLC Has $10.14 Million Position in HealthEquity, Inc. $HQY

Mutual of America Capital Management LLC raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 96,818 shares of the company’s stock after buying an additional 2,513 shares during the period. Mutual of America Capital Management LLC owned about 0.11% of HealthEquity worth $10,143,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its stake in shares of HealthEquity by 24.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company’s stock valued at $564,000 after buying an additional 1,265 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of HealthEquity by 7,983.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company’s stock valued at $2,179,000 after buying an additional 24,350 shares during the period. GAMMA Investing LLC boosted its stake in shares of HealthEquity by 25.9% during the 1st quarter. GAMMA Investing LLC now owns 1,571 shares of the company’s stock valued at $139,000 after buying an additional 323 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after buying an additional 580,988 shares during the period. Finally, WCM Investment Management LLC acquired a new stake in shares of HealthEquity during the 1st quarter valued at $20,230,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $91.46 on Monday. The company has a market capitalization of $7.88 billion, a PE ratio of 55.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.47. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company’s fifty day moving average price is $91.70 and its 200 day moving average price is $94.10.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $325.80 million for the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on HQY shares. Royal Bank Of Canada raised their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. KeyCorp cut their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Raymond James Financial restated a “strong-buy” rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Barrington Research restated an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a report on Friday, August 29th. Finally, JPMorgan Chase & Co. raised their price target on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus target price of $121.31.

Insider Activity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. The trade was a 7.02% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.